Omega Diagnostics Group plc ('Omega' or 'the Company')
Grant of Share Options
Omega announces that on 10 December 2008 the following Directors were granted options over ordinary shares of 4p each in the Company ('Ordinary Shares'):
|
Number of options over Ordinary Shares |
Andrew Shepherd, Chief Executive Officer |
703,480 |
Kieron Harbinson, Finance Director |
468,987 |
David Evans, Non-Executive Chairman |
390,822 |
The options have an exercise price of 19 pence per Ordinary Share. The vesting period begins one year after grant and the options will lapse on the tenth anniversary of grant if not exercised.
The options granted to Andrew Shepherd and Kieron Harbinson are under the Omega Diagnostics Group PLC EMI Option Scheme. The options granted to David Evans are under the Omega Diagnostics Group PLC Unapproved Option Scheme.
Enquiries:
Omega Diagnostics Group PLC
Tel: 01259 763030
Andrew Shepherd, Chief Executive
Kieron Harbinson, Finance Director
www.omegadiagnostics.com
Parkgreen Communications Limited
Paul McManus
Tel: 020 7933 8787
Mob: 07980 541 893
paul.mcmanus@parkgreenmedia.com
Teathers Limited
Jeff Keating
Simon Brown
Tel: 020 7426 9000